Blueprint Medicines Corp (BPMC.O)

+ 收藏

财务摘要(报告期)(Blueprint Medicines Corp)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
每股指标:
 每股收益EPS基本(元) 1.45-8.37-6.55-4.35-2.15-9.35-6.70-4.47-1.79
 每股净资产(元) 5.072.143.345.136.868.5810.7112.5314.80
 每股经营现金净流量(元) -1.66-7.14-5.89-4.18-2.04-8.38-6.37-4.20-2.23
 每股现金流量净额(元) 0.70-0.71-0.97-0.710.82-1.501.37-0.61-2.90
 每股营业收入(元) 1.574.082.921.991.053.402.761.661.05
盈利能力:
 销售毛利率(%) 96.6896.5895.3395.4594.9891.2787.8784.5186.70
 销售净利率(%) 92.74-203.30-223.23-217.08-204.72-273.24-241.37-267.64-168.97
 净资产收益率平均(%) 40.40-157.13-110.43-63.54-27.89-75.07-49.52-30.92-11.44
 总资产净利率(%) 8.54-42.26-32.26-21.36-10.08-42.85-29.43-21.74-8.85
 投入资本回报率ROIC(%) 9.37-45.92-34.75-23.21-11.36-49.07-36.11-25.78-9.87
收益质量:
 营业利润/利润总额(%) -88.2596.1096.4696.3996.2597.3398.24100.4099.99
 税项/利润总额(%) 0.20--------
 经营活动产生的现金流量净额/营业收入(%) -105.62-175.17-201.73-209.70-194.29-246.17-230.48-252.81-211.58
资本结构:
 资产负债率(%) 70.0887.5581.6771.8866.0561.8756.1037.2922.88
 权益乘数 3.348.035.463.562.952.622.281.591.30
 产权比率 2.347.034.462.561.951.621.280.590.30
 流动资产/总资产(%) 74.7877.0473.1273.3373.7877.5484.1879.8560.11
 非流动资产/总资产(%) 25.2222.9626.8826.6726.2222.4615.8220.1539.89
 流动负债/负债合计(%) 28.3923.4021.8721.2521.4221.9421.4535.7052.37
 非流动负债/负债合计(%) 71.6176.6078.1378.7578.5878.0678.5564.3047.63
 归属母公司股东的权益/投入资本(%) 33.5813.3619.3130.1839.4341.8454.8773.3879.71
偿债能力:
 流动比率 3.763.764.094.805.215.716.996.005.02
 速动比率 3.613.664.014.705.115.556.795.774.80
 货币资金/流动负债(%) 54.8533.1728.3644.6898.2965.33166.05109.2227.15
 营业利润/流动负债(%) -38.15-226.26-193.11-149.20-71.93-293.35-220.91-165.94-77.22
 经营活动产生的现金流量净额/流动负债(%) -49.13-203.26-181.33-149.94-71.21-274.12-217.01-158.09-96.86
 归属母公司股东的权益/负债合计(%) 42.6914.2222.4539.1251.4061.6278.27168.15336.98
 经营活动产生的现金流量净额/负债合计(%) -13.95-47.55-39.65-31.87-15.25-60.14-46.56-56.44-50.73
 营业利润/负债合计(%) -10.83-52.93-42.23-31.71-15.41-64.36-47.39-59.24-40.44
成长能力:
 总资产同比增长率(%) -14.90-22.27-24.21-7.216.747.80-1.28-23.99-29.66
 每股净资产同比增长率(%) -26.01-75.12-68.84-59.04-53.68-47.70-49.51-44.80-38.38
 总负债同比增长率(%) -9.719.9910.3478.84208.08196.72255.3385.3016.10
 基本每股收益同比增长率(%) 167.4410.482.242.68-20.1115.08-20.07-24.86-4.07
 归属母公司股东的权益同比增长率(%) -25.01-74.62-68.36-58.39-53.01-46.98-48.66-43.73-37.02
 营业利润同比增长率(%) 36.549.531.694.27-17.3916.27-18.99-26.20-5.55
 营业收入同比增长率(%) 51.8722.227.3621.740.8913.30126.19103.14190.74
 股东权益合计同比增长率(%) -25.01-74.62-68.36-58.39-53.01-46.98-48.66-43.73-37.02
营运能力:
 存货周转率次(次) 0.120.340.360.240.130.690.700.540.32
 流动资产周转率次(次) 0.120.270.190.130.070.250.190.130.10
 固定资产周转率次(次) 2.296.624.803.441.896.375.153.122.03
 总资产周转率次(次) 0.090.210.140.100.050.160.120.080.05
衍生指标:
 现金及现金等价物净增加额TTM(元) -50,831,000.00-43,582,000.00-231,148,000.00-97,046,000.00132,374,000.00-90,008,000.00-261,838,000.00-360,918,000.00-660,667,000.00
 利润总额TTM(元) -287,660,000.00-506,016,000.00-552,771,000.00-551,529,000.00-575,506,000.00-552,281,000.00-710,724,000.00-695,514,000.00-647,185,000.00
 毛利TTM(元) 273,653,000.00240,840,000.00203,076,000.00212,268,000.00188,683,000.00186,223,000.00240,154,000.00195,973,000.00187,258,000.00
 投入资本(元) 925,149,000.00977,964,000.001,049,327,000.001,030,918,000.001,050,646,000.001,230,193,000.001,166,962,000.001,019,047,000.001,106,108,000.00
 经营活动产生的现金流量净额TTM(元) -415,399,000.00-436,847,000.00-479,324,000.00-504,731,000.00-492,512,000.00-502,277,000.00-394,986,000.00-360,692,000.00-305,601,000.00
 总营业收入TTM(元) 282,209,000.00249,380,000.00216,204,000.00225,615,000.00204,592,000.00204,036,000.00272,276,000.00230,487,000.00221,235,000.00
 归属母公司净利润TTM(元) -288,288,000.00-506,984,000.00-554,714,000.00-554,162,000.00-581,078,000.00-557,517,000.00-717,557,000.00-701,635,000.00-650,370,000.00
 所得税TTM(元) 628,000.00968,000.001,943,000.002,633,000.005,572,000.005,236,000.006,833,000.006,121,000.003,001,000.00

前瞻产业研究院